- Patent Title: Indolizine derivatives and their use in neurodegenerative diseases
-
Application No.: US15370645Application Date: 2016-12-06
-
Publication No.: US09931324B2Publication Date: 2018-04-03
- Inventor: Srinivasa R. Karra , Andreas Goutopoulos
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: EMD Serono Research and Development Institute
- Agent Dwight D. Kim
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61K31/437 ; C07D471/04
Abstract:
The present invention relates to indolizine compounds, and pharmaceutically acceptable compositions thereof, useful as antagonists of P2X7, and for the treatment of P2X7-related disorders.
Public/Granted literature
- US20170079965A1 NOVEL INDOLIZINE DERIVATIVES AND THEIR USE IN NEURODEGENERATIVE DISEASES Public/Granted day:2017-03-23
Information query
